Efficacy and Biodistribution of Autologous, Allogeneic, and Xenogeneic Adipose Mesenchymal Stem Cells on Osteoarthritis
W. Wang,X. Lv,M. Li,Z. Sun,F. Wang,L. Zhang,X. Luo,V. Liu,G. Zhao,W. Cao,X. Zhang,R. Wang
DOI: https://doi.org/10.1016/j.joca.2017.02.730
IF: 7.507
2017-01-01
Osteoarthritis and Cartilage
Abstract:Purpose: To investigate efficacy and to correlate it with in vivo biodistribution of autologous, allogeneic, and xenogeneic adipose MSCs on osteoarthritis. Methods: MSCs were isolated from different species of adipose tissue. All animals received humane care in compliance with the “Guide for Care of Laboratory Animals” formulated by the National Ministry of Science (2006). Autologous cells and SVF were isolated from sheep while allogeneic cells were derived from sheep and SD rats, respectively. Xenogeneic cells were come from human AD-MSC. PRP was prepared by harvesting autologous blood from each animal before the induction of anaesthesia. OA were induced in large animals of sheep and New Zealand white rabbits, by anterior cruciate ligament transaction (ACLT) and medial meniscectomy of right knee while in SD rats OA were induced by medial meniscectomy. For efficacy study, all animals were sacrificed at 12 weeks post injection. For biodistribution study, MSCs were labeled with superparamagnetic iron oxides (SPIO) or fluorescence dye. Magnetic resonance imaging (MRI), real-time PCR, macroscopic examination, histological analysis, fluorescence in situ hybridization (FISH) were used to investigate the cell fate and efficacy. Results: Macroscopic evaluations showed that autologous (5 × 107), allogeneic (5 × 107), and xenogeneic (2.5 × 106) MSC treatment in sheep and rabbit models, respectively, ICRS scores demonstrated that efficacy of autologous adipose MSCs is better than autologous SVF and HA while allogeneic MSCs exhibit better efficacy than PRP and HA. When treated with xenogeneic MSCs, ICRS scores was increased compared with HA treatment. Detection thresholds of the labelled MSCs in vitro and in vivo were determined to be 102-104 and 103-105 cells, respectively. MRI results demonstrated that signals of autologous AD-MSCs labeled with SPIO lasted 18 weeks in sheep knee joint while signals of labeled allogeneic AD-MSC lasted 14 weeks in sheep knee joint under T2* sequence. Xenogeneic AD-MSCs labeled with a florescent dye (DiD) remained relatively stable in OA joints and became undetectable after 70 days of injection while in the healthy joints the signal diminished rather quickly at day 28. In order to detect organ distribution, 2.5 × 106 male allogeneic rat adipose MSCs, 2.5 × 106 human adipose MSCs were injected into female SD rat OA knee joint. At the 49 days post injection, male donor DNAs were still present in the injected knee joints, but not in any other tissues/organs. In the xeno-transplantation 14 days post injection, human DNAs were found in muscle and ligament of OA joints while at 70 days after injection, human DNAs were only found in meniscus. Allogeneic and xenogeneic cell DNA were not found in distant organs including heart, liver, spleen, lung, kidney, brain, and ovary. To gain further understanding of the biodistribution of MSCs in the injected joints at the histology and cellular level, we labeled autologous sheep MSCs and injected into joints of the same sheep, SIPO signals were found at meniscus. When labeled allogeneic raMSCs were injected, SPIO signals were found at subchondral bone and meniscus. At 3 days post injection confocal microscopy showed that SPIO+ cells were in the lining of synovial membrane, and were not all co-labeled with CD68, indicating that SPIO signals were not all taken by macrophages (CD68+) via phagocytosis. FISH using Y chromosome probe exhibited allogeneic male raMSCs were found at synovium and subchondral bone. When human MSCs were injected, human mitochondria signals were detected in both meniscus and cartilage with haMSC treatment. Human cells undergoing proliferation by ki67 activity were detected in the joint tissues of haMSC treatment groups. Proteomics of allogeneic MSC treatment detected more than 1,800 proteins in cartilage showing part of the proteins were up-regulated while part of the proteins were down-regulated compared with untreated group. Conclusions: The current study demonstrated PK profile of labeled autologous, allogeneic, and xenogeneic adipose MSCs after IA injection in immunocompetent, surgery-induced OA animal models. Moreover, signals of labeled autologous, allogeneic, and xenogeneic AD-MSC in OA animal models lasted for about 10 weeks, 14 weeks, and 18 weeks in the knee joint at the same time efficacy was observed, respectively. Furthermore, allogeneic and xenogeneic markers could only be detected in the joint, not in other distant organs. Within the knee joint, autologous, allogeneic, and xenogeneic signals could be detected at meniscus, subchondral bone, synovium, and articular cartilage.